Download these slides to review the latest clinical data informing optimal management of β-thalassemia, including for new and emerging novel therapies.
CCO faculty Sujit Sheth, MD, provides insight on the optimal management of β-thalassemia, including review of the latest clinical data on new and emerging novel therapies
CCO CME-certified video featuring expert discussion on new developments in hemophilia A treatment, including extended half-life factor VIII, emicizumab, and more
CCO faculty answer FAQs in hemophilia A, including treatment PK testing and therapy selection: emicizumab, extended half-life factor VIII, and more
You are accessing CCO's educational content today as a Guest user.
If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.